Cue Biopharma, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cue Biopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Cue Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.76M, a 13.8% decline year-over-year.
  • Cue Biopharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was -$326K, a 74.5% increase year-over-year.
  • Cue Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.18K, a 13.9% decline from 2022.
  • Cue Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.5K, a 99.9% decline from 2021.
  • Cue Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.5M, a 9.87% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.18K -$1.32K -13.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $9.5K -$11.5M -99.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $11.5M +$1.03M +9.87% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 $10.5M +$3.96M +60.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 $6.52M -$653K -9.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $7.17M +$4.4M +158% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $2.78M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.